RP
Rhythm Pharmaceuticals Inc
🇺🇸XNAS.RYTMUnited StatesHealthcare
$97.08USDdown -5.36 (-5.23%)OpenEnd of day5:39 PM
Price$97.08-5.36 (-5.23%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US76243J1051
- CUSIP
- 76243J105
Company
- Employees
- 414
- Headquarters
- Boston, United States
- Website
- https://rhythmtx.com
- CEO
- Dr. David P. Meeker M.D.
Market
- Shares outstanding
- 68.9M
- Market cap
- $6.68B
Key dates
- Next earnings
- Nov 3, 2026
Highlights
- Market cap
- $6.68B
- EPS LTM
- -$2.98calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -32.55calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- 0.02%
Fundamentals (LTM)
- Revenue
- $239.92M+53.51%up year on year
- Net income
- -$205.35M-12.17%down year on year
- Gross margin
- 89%-0.28%down year on year
- Free cash flow
- -$150.49M-39.7%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.